A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Skeletal Muscle
Interventions
DRUG

BYM338

BYM338

DRUG

Placebo

BYM338 Placebo

Trial Locations (5)

33143

Novartis Investigative Site, Miami

33169

Novartis Investigative Site, Miami

71913

Novartis Investigative Site, Hot Springs

72201

Novartis Investigative Site, Little Rock

02135

Novartis Investigative Site, Brighton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY